Asthma in America Carries $82 Billion Price Tag

Title: Asthma in America Carries $82 Billion Price TagCategory: Health NewsCreated: 1/12/2018 12:00:00 AMLast Editorial Review: 1/12/2018 12:00:00 AM
Source: MedicineNet Asthma General - Category: Respiratory Medicine Source Type: news

Related Links:

CONCLUSIONS: We demonstrated that the eAAP presented improved asthma control outcomes, but as expected the sample size was inadequate to show a significant difference but based on this pilot study we plan a larger appropriately powered RCT. PMID: 30003851 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
CONCLUSIONS: The improvement in QoL and exacerbation rates with reslizumab are associated with high costs, making reslizumab unlikely to be cost-effective at the $200,000 WTP threshold. PMID: 30003833 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
CONCLUSIONS: Taking the social perspective, the economic impact of severe asthma in Spain was estimated to be €8554/patient/year. PMID: 30003827 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
CONCLUSIONS: Hypocortisolaemia and HPAS could be reversed in asthmatic children treated with physiological doses of steroids by reducing steroid load by 40% and supplementing therapy with steroid-sparing medication. Poor adherence may have either contributed to or retarded HPA recovery. Simultaneously, asthma control improved. Confirmation by a prospective study would be ideal, but may not be feasible. PMID: 30004331 [PubMed - in process]
Source: South African Medical Journal - Category: African Health Tags: S Afr Med J Source Type: research
(MedPage Today) -- Better nutrition linked to better asthma control
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news
A previously healthy, 14-year-old boy presented with chest pain lasting 1 day. He had no complaints of fever, cough, dyspnea, nausea, or vomiting nor did he have any history of asthma or trauma. His height, weight, and body mass index was 165  cm, 44 kg, and 16, respectively. His vital signs were body temperature 37.0°C, heart rate 85/minutes, respiratory rate 24/minutes, and oxygen saturation 98% in room air. Upon physical examination, a crackling sound synchronous with heartbeat, the so-called Hamman's sign, was noted on cardiac a uscultation in the lower left sternal border (Audio; available at www.jpeds.com).
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Rediscovering the Physical Exam Source Type: research
Asthma remains a common and serious public health problem affecting 24 million people in the United States (US). The disease accounts for 1.6 million emergency department visits and 10.5 million physician's office visits each year in the US [3]. Asthma prevalence rates are higher among specific populations such as children, females, ethnic minorities, and those living below the poverty level; many of these groups also have higher rates of asthma related morbidity and mortality [4]. African-Americans with asthma experience disproportionate rates of morbidity and mortality compared to Caucasians [5].
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research
To date, allergen immunotherapy (AIT) is the only treatment that affects the long-term development of allergic rhinoconjunctivitis and induces clinical tolerance primarily by stimulating regulatory T (Treg) cells, attenuating T helper 2 (Th2) responses and synthesis of blocking antibodies1. Conventional AIT with subcutaneous injections, sublingual tablets or drops is effective, but consumes time and resources 2.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research
After completing her fellowship in allergy and immunology, Dr. X accepted an appointment in an academic position at a tertiary care pediatric hospital. Many of the patients Dr. X sees for evaluation of food allergy have undergone serum specific IgE testing prior to their allergy consultation. As time goes on, Dr. X begins to notice a concerning trend in patients referred from Dr. Y, a primary care provider who has been practicing in the community for over twenty years. Dr. X is worried that many of Dr.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Review Source Type: research
Current guidelines recommend the use of anti-inflammatory agents along with moisturizers for the management of atopic dermatitis (AD).1 This approach is prudent, since co-applications of moisturizers under nursing supervision reduce reliance upon topical steroids in AD management.2,3 Yet, some commonly employed moisturizers could harm the skin, if deployed in settings where the barrier already is compromised,3 as in AD. Here, we will compare the key differences between ubiquitous, over-the-counter moisturizers and preparations formulated specifically to correct the biochemical abnormalities in AD.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Clinical Perspective: Source Type: research
More News: Asthma | Respiratory Medicine